2 insider filings
Matthew T David, insider filing for ATNM
Show all 2
- 4Insider filing for ATNM
- 3New insider at ATNM
Matthew T David, reporting
Every EDGAR filing for Actinium Pharmaceuticals, Inc. (ATNM), newest first, with AI summaries and stories.
Next: 10-Q expected ~Nov 9 (deadline Nov 16)
No open-market insider buys in the last 30 days.
Also: 1 grant or exercise.
Matthew T David, insider filing for ATNM
Matthew T David, reporting
Steffen Wilhem Heeger, new insider at ATNM
Steffen Wilhem Heeger, reporting
Sandesh Seth, insider filing for ATNM
Sandesh Seth, reporting